Series A - KinDex Pharmaceuticals
Investment Firm
Overview
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.
Announced Date
Mar 09, 2015
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Jeff Katke |
 Jeffrey Bland |
Round Details and Background
KinDex Pharmaceuticals raised $5500000 on 2015-03-09 in Series A
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 30, 2016 |  Debt Financing - KinDex Pharmaceuticals | - | 327.3K | |
| Mar 09, 2015 | Series A - KinDex Pharmaceuticals | 3 | - | 5.5M |
Recent Activity
There is no recent news or activity for this profile.